MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03848nam a22002897a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
20241106201946.0 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20241106202430.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
241106b |||||||| |||| 00| 0 eng d |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2016936390 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
978-3-319-31212-5 |
|
|---|
| International Standard Book Number |
978-3-319-31214-9 (eBook) |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
ddc |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Fuller form of name |
Michael Bauer |
| 222 ## - KEY TITLE |
|---|
| Key title |
Affect Disord anticonvulsants antidepressant antipsychotics associated Baldessarini RJ Bauer Berghöfer bipolar depression bipolar disorder bipolar II disorder bipolar individuals bipolar patients bipolar spectrum bipolar women carbamazepine Chap clinical clinicians cluster headache comorbid compared decrease depressed patients depressive episodes disease double-blind drug effects of lithium evaluated Gitlin Grof guidelines hypomania hypothyroidism increased Informa Healthcare lamotrigine Lewitzka lithium carbonate Lithium in neuropsychiatry lithium intoxication lithium levels lithium maintenance lithium therapy lithium toxicity lithium treatment lithium-treated patients long-term treatment maintenance treatment major depressive disorder manic episode medications mEq/l meta-analysis monitoring monotherapy mood disorders mood episodes mood stabilizer Müller-Oerlinghausen neuroprotective onset outcome paroxetine patients with bipolar patients with mood placebo polyuria postpartum potential pregnancy prescribed preventing prophylactic quetiapine randomized rapid cycling rates recurrent relapse renal function response to lithium Schou serum levels SGAs side effects symptoms systematic review taking lithium therapeutic thyroid Tondo treating acute mania treatment of bipolar trial unipolar valproate |
| 240 ## - UNIFORM TITLE |
|---|
| Uniform title |
The Essential Guide to Lithium Treatment. |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
The Essential Guide to Lithium Treatment. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Technische Universtät Dresden University Hospital Carl Gustav Carus Dresden Germany | |
| Name of publisher, distributor, etc. |
Springer International Publishing Switzerland | |
| Date of publication, distribution, etc. |
2016 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
167 Pages |
|
|---|
| Extent |
Includes References and Index |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
<br/>This book is a practical, up-to-date guide to the correct use of lithium for the short- and long-term treatment of mood disorders. Among the subjects addressed are the pharmacology and mechanisms of action of lithium, its use for maintenance treatment, the role of lithium in the treatment of mania and depression and in suicide prevention, further clinical indications, the administration of lithium during pregnancy and the postpartum period, and adverse effects and their management. Relevant background information is provided on the diagnosis, classification, and natural course of mood disorders, and an overview of other treatments for bipolar disorder and major depression is included. Lithium is the essential medication for patients with mood disorders. The evidence of its efficacy in maintenance treatment is acknowledged in all major international treatment guidelines for bipolar disorders and, when used correctly, lithium unquestionably produces the most dramatic benefits of any medication in psychopharmacology. This essential guide is written by two international experts in the treatment of mood disorders who have more than 25 years of experience in the use of lithium and have authored numerous scientific articles on lithium. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| General subdivision |
Clinical psychology, Medical / Pharmacology, Medical / Pharmacy, Medical / Psychiatry / Psychopharmacology, Psychiatry, Psychology / Clinical Psychology, Therapeutics, Medical / Diseases, Medical / Internal Medicine, Medical / Physical Medicine & Rehabilitation, Medical / Psychiatry / General, Chemotherapy, Electronic books, Lithium -- Therapeutic use, Medicine, Psychology, clinical, Psychopharmacology. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Fuller form of name |
Michael Gitlin |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="DOI 10.1007/978-3-319-31214-9">DOI 10.1007/978-3-319-31214-9</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
ddc |
| Koha item type |
E-BOOKS |
| Suppress in OPAC |
|
